BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20160101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171128
DTEND;VALUE=DATE:20171130
DTSTAMP:20260515T105356
CREATED:20170829T093920Z
LAST-MODIFIED:20170829T094210Z
UID:2969-1511827200-1511999999@www.pharmajournalist.com
SUMMARY:Pharma and Device Packaging and Labeling West Coast 2017
DESCRIPTION:Following a very successful launch year\, we are thrilled to announce that Pharma and Device Packaging and Labeling will be returning to the West Coast for our 2nd annual event. \nBringing together those involved in packaging\, labeling and supply chain in both pharmaceutical and medical device companies\, this event offers you the only chance to discuss\, deliberate and debate the pressing issues for the industry. With varied subjects covered from Core Data Sheet to UDI\, packaging innovation to artwork management and everything in between\, our 2017 show promises to bring you even more relevant and divisive content. \n\nA look back at our inaugural 2016 event… \nIn 2016 we launched our successful Pharma Packaging and Labeling USA event in San Francisco\, after many successful ongoing years in Philadelphia. Bringing together both the pharmaceutical and medical device industries in the area\, our agenda focused on the commercial packaging and labeling challenges and innovations shaking up the industry now and in the future.
URL:https://www.pharmajournalist.com/event/pharma-device-packaging-labeling-west-coast-2017/
LOCATION:Burlingame\, California
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171128
DTEND;VALUE=DATE:20171130
DTSTAMP:20260515T105356
CREATED:20171018T003307Z
LAST-MODIFIED:20171018T003542Z
UID:3481-1511827200-1511999999@www.pharmajournalist.com
SUMMARY:Ophthalmic Drugs
DESCRIPTION:SMi Group are thrilled to announce the launch of the Ophthalmic Drugs Conference\, being held on the 28-29 November 2017 at the Copthorne Tara Hotel in London\, UK. \n \nOcular disease therapy has seen a surge in innovation in areas ranging from glaucoma to macular degeneration and diabetic retinopathy. As ageing populations grow globally the need for treatment in this field has grown and is expected to reach a figure of $21 billion by the year 2022. – (Source: Business Wire –http://bit.ly/2rlECrh) \nOphthalmic Drugs will gather industry leaders to discuss the latest challenges and changes in the field of ophthalmology. Explore novel approaches to treatment\, ocular medical devices\, targeted drug delivery technology and real-life challenges to pre-clinical and clinical trials\, to deepen your understanding of inherited ocular diseases. \n‘By far the most important organs of sense are our eyes. We perceive up to 80 per cent of all impressions by means of our sight. And if other senses such as taste or smell stop working\, it’s the eyes that best protect us from danger.’ – (Source: Zeiss –http://bit.ly/2tl5iua) \nHow Will You Benefit? \nNetwork and learn from leading professionals such as: \n– Naj Sharif\, Executive Director in R&D\, Head\, Global Alliances & External Research\, Santen Inc\n– Mitchell de Long\, Vice President\, Chemistry\, Aerie Pharmaceuticals\n– Michael Lai\, Global Program Medical Director\, Novartis\n– Sérgio Leal\, Ophthalmologist Director\, Global Clinical Leader\, Bayer\n– Victor Chong\, Global Head of Ophthalmology\, Boehringer Ingelheim\n– Amir Shojaei\, Vice President Therapeutic Area Head\, Ophthalmology\, Shire\n– Tomas Navratil\, Senior Vice President\, Development\, Envisia Therapeutics \nVisit the website for the full speaker line-up: www.ophthalmicdrugs.com/pj \nSome of the featured highlights will include: \n– New approaches to drug delivery to the back of the eye and nanotechnology\n– Discover innovation in diagnostic technology\n– Regulatory keynote on medical devices and human factors\n– Explore various combination products improving health outcomes\n– Exciting insight into stem cell and gene therapy \nView the full agenda: www.ophthalmicdrugs.com/pj
URL:https://www.pharmajournalist.com/event/ophthalmic-drugs/
LOCATION:London\, UK
ORGANIZER;CN="SMi Group Ltd":MAILTO:psolanki@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171129
DTEND;VALUE=DATE:20171201
DTSTAMP:20260515T105356
CREATED:20170718T041426Z
LAST-MODIFIED:20170718T041608Z
UID:2519-1511913600-1512086399@www.pharmajournalist.com
SUMMARY:Clinical Trial Supply Southern California 2017
DESCRIPTION:Clinical Trial Supply Southern California returns for another year to La Jolla\, San Diego. Once again it promises to deliver some of the most cutting edge content in the world of Clinical Trial Supplies.\n \nStandout speakers for 2017 include those from Ionis\, Intercept and Acadia\, but the event also featured some innovative biotech companies from the local area Valley Fever Solutions and Prometheus Laboratories. \nFor more information visit – http://www.arena-international.com/ctssocal
URL:https://www.pharmajournalist.com/event/clinical-trial-supply-southern-california-2017/
LOCATION:La Jolla\, San Diego (Venue TBC)
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
END:VCALENDAR